Carbamazepine and/or Fluvoxamine Drug Interaction with Risperidone in a Patient on Multiple Psychotropic Medications

Abstract

Get full access to this article

View all access options for this article.

References

Spina

Martines

Caputi

Cobaleda

Piñas

Carrillo

Debrisoquine oxidation phenotype during neuroleptic monotherapy. Eur J Clin Pharmacol 1991;41:467–70.

Fang

Bourin

Baker

. Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450, 2D6, and 3A4. Naunyn Schmiedebergs Arch Pharmacol 1999;359: 147–51.

de Leon

Bork

. Risperidone and cytochrome P450 3A (letter). J Clin Psychiatry 1997;58: 450.

Carrillo

Dahl

Svensson

Alm

Rodríguez

Bertilsson

. Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity. Clin Pharmacol Ther 1996;60: 183–90.

Katz

Jeste

Mintzer

Clyde

Napolitano

Brecher

. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. J Clin Psychiatry 1999;60: 107–15.